Clinical Trials Browser

Phase 2/3 × Stomach Neoplasms × Immunotherapy × Clear all

NCT07000253 2026-05-07

OMEC-5

Phase 2/3 Recruiting

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms